Longitudinal automated brain volumetry vs. expert visual assessment of atrophy progression on MRI is robust but caution is advised
View ORCID ProfileMax Gebest, Christel Weiß, Chang-Gyu Cho, Lucrezia Hausner, Lutz Frölich, Alex Förster, Nandhini Santhanam, Johann Fontana, Christoph Groden, Holger Wenz, View ORCID ProfileMáté E. Maros
doi: https://doi.org/10.1101/2024.05.21.24306349
Max Gebest
1Department of Neuroradiology,
Christel Weiß
3Department of Medical Statistics, Biomathematics and Information processing, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1–3, 68137 Mannheim, Germany
Chang-Gyu Cho
1Department of Neuroradiology,
Lucrezia Hausner
4Central Institute of Mental Health (ZI/CIMH), J5, 68159 Mannheim, Germany
Lutz Frölich
4Central Institute of Mental Health (ZI/CIMH), J5, 68159 Mannheim, Germany
Alex Förster
1Department of Neuroradiology,
Nandhini Santhanam
2Department of Biomedical Informatics at the Center for Preventive Medicine and Digital Health (CPD),
Johann Fontana
5Department of Anesthesiology and Intensive Care Medicine, BG Trauma Center Tuebingen, 72076 Tuebingen, Germany
Christoph Groden
1Department of Neuroradiology,
Holger Wenz
1Department of Neuroradiology,
Máté E. Maros
1Department of Neuroradiology,
2Department of Biomedical Informatics at the Center for Preventive Medicine and Digital Health (CPD),
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted May 21, 2024.
Longitudinal automated brain volumetry vs. expert visual assessment of atrophy progression on MRI is robust but caution is advised
Max Gebest, Christel Weiß, Chang-Gyu Cho, Lucrezia Hausner, Lutz Frölich, Alex Förster, Nandhini Santhanam, Johann Fontana, Christoph Groden, Holger Wenz, Máté E. Maros
medRxiv 2024.05.21.24306349; doi: https://doi.org/10.1101/2024.05.21.24306349
Longitudinal automated brain volumetry vs. expert visual assessment of atrophy progression on MRI is robust but caution is advised
Max Gebest, Christel Weiß, Chang-Gyu Cho, Lucrezia Hausner, Lutz Frölich, Alex Förster, Nandhini Santhanam, Johann Fontana, Christoph Groden, Holger Wenz, Máté E. Maros
medRxiv 2024.05.21.24306349; doi: https://doi.org/10.1101/2024.05.21.24306349
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)